• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hurdle, CloudLIMS Partner to Augment Diagnostic Lab Capabilities

Share:

February 21, 2023

What You Should Know:

– Hurdle (a Chronomics Inc. brand), a global bio-infrastructure platform that powers end-to-end diagnostics for life sciences, labs and healthcare providers, and CloudLIMS, a leading SOC 2 compliant and ISO 9001:2015 certified lab informatics provider, announced today that the companies have entered into a strategic partnership marking the first integration between a Diagnostic as a Service (DaaS) platform and a Software-as-a-Service (SaaS) LIMS provider.

– The partnership brings together Hurdle’s remote diagnostic platform and CloudLIMS’s secure, purpose-built diagnostics LIMS to empower labs with the ability to offer at-home tests, and manage lab processes and data efficiently.

Helping Diagnostic Labs Stay Ahead of the Competition By Extending Remote Diagnostic Testing Services

As a result of this collaboration, Hurdle’s partner labs, such as reference labs and clinical diagnostic labs, will now be able to seamlessly manage lab data, automate workflows, and follow regulatory compliance, such as HIPAA, GDPR, CLIA, ISO 15189:2022.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Many labs today want to offer remote diagnostic services to provide direct-to-patient and direct-to-provider services, saving the time of both patients and providers. Diagnostic labs will now be able to extend their services to patients present in infectious disease hotspots, remote locations, and to underserved communities who are unable to travel to the lab location to get themselves tested. Labs can also improve their offering to existing B2B customers by providing Hurdle’s white-labeled kits.

“Labs using Hurdle are now able to enjoy a completely integrated experience while managing remote diagnostic journeys, which will have a positive impact for all customers,” said Tom Stubbs, co-founder and CEO of Hurdle. “The pandemic highlighted a global need for remote diagnostics while simultaneously exposing a fragmented infrastructure ill-equipped to meet the demand. Today, we’re happy to provide labs with fully integrated and efficient solutions through our dedicated diagnostics infrastructure so that they in turn can continue to support today’s providers and patients.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Comcast Spinoff Quil Unveils Home-Based Sensor Network for SeniorsComcast Spinoff Quil Unveils Home-Based Sensor Network for Seniors
  • Crown Bioscience to Acquire Indivumed’s Service Business and Supporting BiobankCrown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
  • Bigfoot Biomedical Caps Off Its Series C Funding at $55M, Including a New $10m AdditionBigfoot Biomedical Caps Off Its Series C Funding at $55M, Including a New $10m Addition
  • Global Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & SarcoMed USAGlobal Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & SarcoMed USA
  • Agragene’s Knock-Out™ Product Utilizes Live Sterile Male Insects as a Form of Insect Pest ControlAgragene’s Knock-Out™ Product Utilizes Live Sterile Male Insects as a Form of Insect Pest Control
  • St. Croix Hospice Acquires Hometown Hospice & HomecareSt. Croix Hospice Acquires Hometown Hospice & Homecare
  • Zomedica Acquires PulseVetZomedica Acquires PulseVet
  • Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-Oncology PortfolioBoehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-Oncology Portfolio

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications